If you require further searching capabilities for announcements please email: data@nzx.com
2 July 2024 2024 Annual Shareholder Meeting and Director Nominations Blis Technologies Limited’s 2024 Annual Shareholder Meeting will be held at Dunedin Public Art Gallery, Auditorium, 30 The Octagon, Dunedin on Wednesday, 28 August 2024 commencing at 11.00 am. This meeting will also be hosted virtually. Further details regarding the meeting will be provided in the Notice of Meeting which will be sent to all shareholders at least 20 working days prior to the meeting. The closing date for nominations by shareholders of directors to be considered for election at the Annual Shareholder Meeting is Tuesday, 16 July 2024. Nominations may be made by a shareholder entitled to attend and vote at the Annual Shareholder Meeting and must be accompanied by a consent in writing by a nominated person. Nominations should be addressed by mail or email to: Richard Wingham Chief Financial Officer Blis Technologies Limited PO Box 2208 Dunedin 9044 Email: richard.wingham@blis.co.nz Ends For further information, please contact: Richard Wingham Chief Financial Officer +64 21 284 0446 About Blis Technologies Ltd Delivering proven health benefits through evidence-based, advanced probiotics Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS® products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at www.blis.co.nz. Website: www.blis.co.nz Instagram: @blisprobiotics #blisk12 #blism18 #blisq24 Facebook: @BLISProbiotics